|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0027651,
umls-concept:C0030705,
umls-concept:C0031268,
umls-concept:C0032743,
umls-concept:C0046056,
umls-concept:C0205210,
umls-concept:C0332305,
umls-concept:C0443252,
umls-concept:C1274040,
umls-concept:C1707455
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2005-9-13
|
|
pubmed:abstractText |
Extraaxillary metastases (i.e., in the absence of axillary involvement) are more likely to develop in patients with inner-quadrant (IQ) breast cancer than in patients with outer-quadrant (OQ) primary tumors. The relative difficulty of identifying extraaxillary metastases may lead to understaging of cancer in these patients. This study examined whether (18)F-FDG PET findings were differentially associated with the location of primary tumors, and with long-term prognosis, in IQ and OQ patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1455-9
|
|
pubmed:meshHeading |
pubmed-meshheading:16157527-Breast Neoplasms,
pubmed-meshheading:16157527-Female,
pubmed-meshheading:16157527-Fluorodeoxyglucose F18,
pubmed-meshheading:16157527-Humans,
pubmed-meshheading:16157527-Longitudinal Studies,
pubmed-meshheading:16157527-Middle Aged,
pubmed-meshheading:16157527-Positron-Emission Tomography,
pubmed-meshheading:16157527-Prognosis,
pubmed-meshheading:16157527-Radiopharmaceuticals,
pubmed-meshheading:16157527-Reproducibility of Results,
pubmed-meshheading:16157527-Retrospective Studies,
pubmed-meshheading:16157527-Risk Assessment,
pubmed-meshheading:16157527-Risk Factors,
pubmed-meshheading:16157527-Sensitivity and Specificity,
pubmed-meshheading:16157527-Severity of Illness Index
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome.
|
|
pubmed:affiliation |
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.
|
|
pubmed:publicationType |
Journal Article
|
